RFA-CA-19-025 - Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 1

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Availability of Funds for Revision Applications for Research Centers with a Focus in Chronic Disease and the Reduction of Health Disparities (P50, P30, U54) NOT-OD-19-070 NIH Feb 11, 2019 Mar 29, 2019 P30, P50, U54
For technical issues E-mail OER Webmaster